Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENN domain-containing protein 4C (DENND4C) is a guanine nucleotide exchange factor (GEF) that activates the small GTPase Rab10 by facilitating the exchange of GDP for GTP, converting inactive GDP-bound Rab10 to its active GTP-bound form[1][2][4]. DENND4C plays a crucial role in insulin-regulated glucose uptake, particularly in adipocytes where it localizes to GLUT4 storage vesicles and enables their mobilization to the plasma membrane in response to insulin, thereby facilitating glucose transporter delivery to the cell surface[1][4]. It also interacts with the retromer complex involved in endosomal protein sorting, with dysfunction in these pathways linked to neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases[2][3]. DENND4C is part of the broader DENN domain family, a major subgroup of Rab GEFs, and is also implicated in metabolic homeostasis and potentially in a range of human disorders connected to vesicle trafficking and signal transduction[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENN domain-containing protein 4C (DENND4C).